Introduction
The rising prevalence of chronic
diseases, such as anemia and leukemia, is a major factor driving the growth of
the hematology analyzers market. Additionally, the increasing demand for
point-of-care testing, which is expected to reduce the time required for
diagnosis, is expected to fuel the market growth. Furthermore, technological
advancements, such as the introduction of automated hematology analyzers, are
also expected to drive the market growth.
Global
Hematology Analyzers and Reagents Market Overview
The report Hematology Analyzers and
Reagents Market is projected to reach USD 10.6 billion
by 2025 from USD 7.6 billion in 2020, at a CAGR of 6.9% during the forecast
period.
The increasing
incidence of blood disorders and the growth in the number of blood donation are
the major factors driving the growth of the global hematology analyzers and
reagents market. Technological advancements in hematology analyzers and
reagents and the integration of flow cytometry techniques with hematology
analyzers are also expected to support the growth of this market during the
forecast period.
Ask
for PDF Brochure: –https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=153222146
Market
Segmentation: -
On the basis of
products & services, the hematology reagents market is classified into
hematology, hemostasis, and immunohematology products & services. The
hematology products & services segment is projected to grow at the highest
growth rate during the forecast period.
By end user, the
hematology analyzers market is segmented into hospital laboratories, commercial
service providers, government reference laboratories, and research &
academic institutes. In 2019, the commercial service providers segment
accounted for the largest share of the market due to factors such as the
increasing awareness about hematology testing, shift from manual testing to
automated testing, and the competitive benefits offered by these providers as
compared to hospitals (such as affordable service costs, efficient turnaround
time, and efficient management of sample collection).
Regional
Analysis: -
North America
accounted for the largest share of the market in 2019. This can be attributed
to the rising incidence of patients suffering from blood disorders, the growing
prevalence of target diseases, and the rising demand for blood transfusions in
the region.
Request
for Sample Pages: – https://www.marketsandmarkets.com/requestsampleNew.asp?id=153222146
Recent
Developments: -
- In February 2018, Sysmex entered into an
agreement with McKesson to distribute Sysmex’s XW-100 automated hematology
analyzers in the US.
- In September 2017, Sysmex entered into an
agreement with Mongolia’s Ministry of Health to provide technological,
scientific, and external quality assessment support in the field of blood
morphology to raise the accuracy of testing in the Mongolian region.
- Sysmex expanded its direct sales network
in the Republic of Ghana (Africa) to reinforce its hematology sales and
service structure in the African market.
- In July 2017, Sysmex launched XN-9100,
XN-3100, XN-1500, and SP-50 (an automated hematology slide preparation
unit).
- In July 2017, Sysmex launched the XN-L
automated hematology analyzers in the US.
Top
key Players: -
The major players in
the global hematology reagents market are Sysmex Corporation (Japan), Abbott
Laboratories (US), Danaher Corporation (US), Nihon Kohden (Japan), Siemens
(Germany), Boule Diagnostics (Sweden), HORIBA (Japan), Bio-Rad Laboratories
(US), BioSystems (Spain), Diatron (Hungary), Drew Scientific (US), EKF
Diagnostics (UK), Mindray (China), Ortho Clinical Diagnostics (US), and Roche
(Switzerland).
No comments:
Post a Comment